Research study Program year 2025 Source: CMS Open Payments

Phase 2 Double Blind Randomized Study in IPF and SSc ILD

Research payments

$3,755,723

397 payments

Through program year 2025, $3,755,723 in research payments was reported against Phase 2 Double Blind Randomized Study in IPF and SSc ILD, across 397 payments, paid by Genentech, Inc..

Paid by: Genentech, Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

3 rows

Year	Kind	Amount	Payments
2025	Research	$1,729,821	155
2024	Research	$1,618,322	184
2023	Research	$407,580	58

Breakdown

Who paid Research payments · program years 2023–2025

Genentech, Inc. $3,755,723 397 payments

Who received the money Research payments · program years 2023–2025

Elligo Health Research INC Organisation paid for research $772,345 48 payments
Uc Davis Medical Center Teaching hospital · CA $387,898 16 payments
Renstar LLC Organisation paid for research $378,886 42 payments
Pulmonix LLC Organisation paid for research $376,774 68 payments
University Of Alabama Hospital Teaching hospital · AL $321,693 13 payments
The University Of Texas Health Organisation paid for research $182,697 15 payments
Board Of Regents Of The University Of Oklahoma Health Sciences Center Organisation paid for research $160,937 13 payments
Southeastern Research Center Organisation paid for research $132,330 11 payments
Hannibal Regional Healthcare System INC Organisation paid for research $89,181 18 payments
The Regents Of The University Of California Ucla Organisation paid for research $80,250 6 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

6 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.